Search

everythinglearnresearchcommunity

for

Search:↓

Taking 5 mg/day finasteride can cause side effects in women with hair loss, but these are usually mild and fade over time, making the treatment beneficial in the long run.

Finasteride and intense pulsed light effectively reduce unwanted facial hair in women, but may not be cost-effective.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

PRP therapy with Derma roller effectively promotes hair re-growth and reduces hair fall in women with pattern hair loss.

Hair coloring, waving, and ironing cause more hair damage than not using these treatments.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Menopause affects hair and skin; more research needed for treatment.

Changes in scalp bacteria are linked to female hair loss, suggesting new treatment options.

Dr. SKS Hair Booster Serum effectively treats hair loss in women with PCOS.

The combination of hair follicle stem cells and PRP shows promise for treating hair loss in Asian men and women.

Many female students at Northern Border University in Saudi Arabia may have Polycystic ovary syndrome (PCOS) and related emotional distress, so those at risk should get further tests and treatment.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

A young woman with a rare hair loss condition improved with steroid and biotin treatment.

Stopping and restarting JAK inhibitors during pregnancy in women with alopecia areata leads to hair loss and regrowth, with most pregnancies resulting in healthy babies.

Hirsutism in women is often caused by hormonal imbalances and can be managed with treatments targeting the underlying cause.

Men and women need different facial rejuvenation treatments due to distinct aging processes and anatomical differences.

Asian women often experience distinct hair thinning at the top of the head.

Spironolactone treatment increases the amount of testosterone available in the body.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Over 40% of women have unwanted facial hair, which can affect their self-image, and should be managed with personalized treatment and support.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

A woman's scalp nodules were successfully treated with antifungal and anti-lice medications, revealing a rare case of mixed piedra infection.

A woman's premature gray hair turned mostly black again after using Greyverse solution and hair supplements for 5 months.

A woman developed permanent hair loss after a face-lift surgery despite various treatments.

Laser hair removal by trained professionals is the most effective long-term method for reducing facial hair in women.

Female pattern hair loss in women can be due to hormones or aging.

Pregnancy skin issues can lead to complications, seborrheic dermatitis is linked to STDs, community education helps homeless women's skin, topical timolol is safe for infant hemangiomas, synthetic progestins affect melasma risk, and hijab-related hair loss affects mental health, with cultural barriers limiting treatment access.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Telogen Effluvium (TE) significantly affects women due to stress and hormonal changes, requiring better public health policies and mental health support.